May is Ocular Melanoma Awareness Month
Ocular (uveal) melanoma is a rare but dangerous disease, and only a small number of doctors in the United States treat it. At Texas Retina, we have been caring for ocular melanoma
read more
Dr. Abbey Shares 36-Month Results of Pegcetacoplan Treatment for Geographic Atrophy in AMD
On behalf of the investigators for the OAKS, DERBY, and GALE clinical trials, Texas Retina’s Director of Clinical Research for Dallas, Ashkan Abbey, MD, co-authored an article titled, “Pegcetacoplan Treatment for Geographic
read more
Dr. Nikisha Kothari Leads Eyetube Interview on a Challenging Surgical Case
Texas Retina’s Nikisha Kothari, MD, recently interviewed one of the 2025 Vit-Buckle Society Meeting presenters about a challenging case for Eyetube. She talked with Andrew Tsai, MD, an adult and pediatric retinal
read more
Dr. Laura Discussed Dry AMD Treatment at 2025 Vit-Buckle Society Annual Meeting
Texas Retina’s Diana M. Laura, MD, participated in a debate at the 13th Annual Vit-Buckle Society Meetingheld recently in Austin, Texas, where she discussed the role of complement inhibitors for the treatment
read more
Dr. Kothari Speaks About Rare Retinal Conditions at 2025 VitBuckle Society Annual Meeting
Texas Retina’s Nikisha Kothari, MD, served on a medical retina panel that reviewed rare retinal conditions, ranging from medication related toxicity and genetic disorders to infectious diseases, at the 13th Annual Vit-Buckle
read more
Dr. Anand Led North Dallas YMCA Community Outreach Program on Eye Health
On Saturday, March 15, 2025, Texas Retina’s Rajiv Anand, MD, partnered with Matthew E. Emanuel, MD, of Glaucoma Associates of Texas, to help educate members of the Semones Family YMCA in North
read more
Texas Retina Clinical Research Coordinator Rachel McCullough Participates in Panel Discussion for LUGANO and LUCIA Clinical Trials
At a recent meeting in San Antonio, Texas Retina Clinical Research Coordinator Rachel McCullough participated in a panel discussion with study coordinators for EyePoint Pharmaceuticals’ pivotal Phase III LUGANO and LUCIA clinical
read more
Protect Your Eyes at Work
About 2,000 workers sustain job-related eye injuries each day according to the American Academy of Ophthalmology. Did you know that 90% of these injuries could have been avoided by wearing proper eye
read more
The Ohio State University Recognizes Dr. Wang for Giving Back
In the latest issue of BuckEye Ophthalmology, The Ohio State University Department of Ophthalmology & Visual Sciences featured Texas Retina’s Robert C. Wang, MD, for giving back through the George & Shirley
read more
10 New Clinical Trials Available at Texas Retina
In the last two decades, medical researchers have made significant advances in the diagnosis and treatment of retina conditions, discovering new sight-saving treatments for diseases that once robbed patients of their vision.
read more